Nothing Special   »   [go: up one dir, main page]
Scribd Logo
Upload

Welcome to Scribd!

  • 125 views

    Pre Eclampsia Drug Stufy

    Uploaded by

    Frances Reina Tabadero
    This document summarizes key information about 4 drugs: Hydralazine, Magnesium Sulfate, Dexamethasone, and Methyldopa. For each drug, it provides the drug name, indications/actions, potential adverse effects/side effects, nursing assessments, and nursing responsibilities. The nursing assessments and responsibilities involve monitoring for common or serious side effects, assessing patient symptoms, monitoring vital signs and lab tests, and educating patients about adherence and reporting side effects.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Pre Eclampsia Drug Stufy

    Uploaded by

    Frances Reina Tabadero
    125 views3 pages
    This document summarizes key information about 4 drugs: Hydralazine, Magnesium Sulfate, Dexamethasone, and Methyldopa. For each drug, it provides the drug name, indications/actions, potential adverse effects/side effects, nursing assessments, and nursing responsibilities. The nursing assessments and responsibilities involve monitoring for common or serious side effects, assessing patient symptoms, monitoring vital signs and lab tests, and educating patients about adherence and reporting side effects.

    Original Description:

    Original Title

    pre eclampsia drug stufy

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes key information about 4 drugs: Hydralazine, Magnesium Sulfate, Dexamethasone, and Methyldopa. For each drug, it provides the drug name, indications/actions, potential adverse effects/side effects, nursing assessments, and nursing responsibilities. The nursing assessments and responsibilities involve monitoring for common or serious side effects, assessing patient symptoms, monitoring vital signs and lab tests, and educating patients about adherence and reporting side effects.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    125 views3 pages

    Pre Eclampsia Drug Stufy

    Uploaded by

    Frances Reina Tabadero
    This document summarizes key information about 4 drugs: Hydralazine, Magnesium Sulfate, Dexamethasone, and Methyldopa. For each drug, it provides the drug name, indications/actions, potential adverse effects/side effects, nursing assessments, and nursing responsibilities. The nursing assessments and responsibilities involve monitoring for common or serious side effects, assessing patient symptoms, monitoring vital signs and lab tests, and educating patients about adherence and reporting side effects.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3

    Drug Name Drug Action Adverse effect/Side Nursing Nursing

    effects assessment/Pt. Responsibility


    Assessment
    1.Hydralazine HCL
    Indications: CNS:dizziness,drowsiness, -Monitor blood pressure
    a. Brand Name: Apresoline -Management of heart headache; and pulse frequency
    hcl failure to patients. during initial dose
    b. Generic name: CV:tachcardia,angina,arrhyt adjustment report
    Hydralazine Action: hmias, significant changes.
    c. Classifications: -Vasodilator w/effects on edema,orthostatic -Monitor frequency of
    Therapeutic: vasodilatorsboth arteries and hypotension prescription refills to
    Pharmacologic: veins,and hydralazine,a determine adherence.
    vasodilators predominantly arterial GI:diarrhea,nausea,vomiting -Lab test consideration:
    vasodilators. If symptoms of systemic
    d. Dose/Route: PO(Adults): 1 - Therapeutic effect: DERM:Rashes lupus erythematosus
    tab TID ,may be increased to Improved occur obtain a CBC and
    2 tab TID survival,increase time to ANA titer.
    hospitalization and
    decrease symptoms of
    f. Frequency: heart failure.

    2.Magnesium Sulfate
    Indication: Treatment of CNS:drowsiness. Hypermagnesemia,hyop
    a. Brand Name: magnesium hypertension. calcemia,anuria,heat
    sulfate Anticonvulusant Resp: decreased RR. block,active labor within
    b. Generic name: associated 2 hrsof delivery
    c. Classification: w/eclampsia,pre- CV:arrhythmias,bradicarrdia
    Therapeutic: mineral and eclampsia or acute ,hypotension; Use Causiously:any
    electrolyte replacement nephritis. degree of renal
    Pharmacologic: GI:diarrhea;MS:muscle insufficiency
    minerals/electrolytes Action: Essential for the weakness.;
    activity of many
    d. Dose/Route: IV,IM (adults) enzymes.Plays an DERM:flushing,sweating.
    Eclmapsia/Pre-eclampsia— important role in the
    4-5 by IV infusion, neurotransmission and Metab:hypothermia
    concurrently w/ up to 5 g IM muscular excitability.
    in each buttocks;then4-5 g
    IM q 4 hr by IV infusion Therapeutic Effect:
    followed by 1 -2 g/hr Replacement in
    continous infusion. deficiency states.
    e. Frequency: Resolution of eclampsia.

    3. Dexamethasone
    Suppresion of CNS:depression,euphoria,h Asses involves systems
    a.Brand Name inflammation and eadache,increased before and periodically
    :dexamethasone intensol modification of the intracranial pressure therapy
    b. Generic Name: normal immune - Monitor intake
    Dexamethasone response. Replacement CV:hypertension and ouputs ratio
    c. Classification: therapy in adrenal and daily weights
    Corticosteroids insufficiency GI:anorexia,nausea, - Cerebral edema:
    vomiting assess patient for
    d.Dose/Route:PO,IM,IV; MS:muscle wasting, changes in level
    (antiniflamatory—0.75-9 md osteoporosis of consciousness
    dailr in divided doses q 6 -12 and headache
    hours. during therapy.
    - Airway edema or
    extubation---0.5-2 mg/kg
    daily divided q 6hr. beginning
    24 hr. prior to extubation and
    continoue for 24 hr
    extubation.
    -Cerebral edema—10 mg
    IV ,then 4 mg IM or IV q 6 hr
    until maximal response
    achieved ,then swithch to PO
    regimen and tape over 5-7
    days.

    4. Methyldopa
    Indication: management -monitor BP and pulse
    a. Brand Name: methldopa of moderate to severe CNS: sedation frequency during initial
    b: Generic nae: methyldopa hypertension dose adjustmenyt and
    c:Classification: GU:erectile dysfunction periodically during
    Action : Lowering of therapy.
    Therapeutic:antihypertensive blood pressure EENT: nasal stuffiness -assess patient for
    s depression or other
    Pharmacologic:centrally mental status
    acting antiadrenegics -monitor temp during
    therapy.Drug therapy
    d.Route/Dosage: PO (adults) may occur shortly after
    250-500 mg 2-3 times a inhalation of therapy
    day ;may be increased q2
    days as needed;usual
    maintenance dose is 500mg
    —2g/day (not to exceed
    3g/day)

    You might also like